Henry Brem, MD, is the Harvey Cushing Professor of Neurosurgery at The Johns Hopkins University, director of the Department of Neurosurgery and neurosurgeon-in-chief of The Johns Hopkins Hospital. He also is a professor of oncology, ophthalmology and biomedical engineering.
Doctor Brem has developed new tools and techniques that have changed the field of neurosurgery. He carried out the pivotal clinical study that introduced navigational imaging into the neurosurgical suite. His work led to the FDA's approval of the first image guidance computer system for intraoperative localization of tumors. Furthermore, Doctor Brem has changed the surgical armamentarium against brain tumors by inventing and developing Gliadel® wafers with Robert Langer of MIT to intraoperatively deliver chemotherapy to brain tumors. His work shows that surgeons can accurately deliver potent therapies directly at the tumor site.
Doctor Brem earned his undergraduate degree from New York University and his medical degree from Harvard Medical School, and he trained in neurosurgery at Columbia University. At Johns Hopkins, he has built one of the largest brain tumor research and treatment centers in the world. He reinstituted the Hunterian Neurosurgery Laboratory originally founded by Harvey Cushing, and he has trained researchers who have revolutionized the fields of intraoperative imaging, angiogenesis, immunotherapy and controlled release polymers for drug delivery to the brain. In 1998, Doctor Brem was elected to the Institute of Medicine of the National Academy of Sciences. In 2014, The Johns Hopkins University established the Henry Brem Endowed Chair in Neurosurgery. In 2015 Brem was selected to receive a Castle Connolly National Physician of the Year Award for Clinical Excellence. The award is given annually to five physicians whose dedication, talents and skills have improved the lives of thousands of people throughout the world.
Over the past 30 years, Doctor Brem has introduced new therapeutic approaches to neurosurgery. His dedication to patient care, clinical excellence, innovation, teaching and translational science has brought together a unique group of neurosurgeons and investigators and industrialists who are changing the field of neurosurgery.
PROGRAM AGENDA:
6-7 p.m. Registration and reception
7-7:15 p.m. Welcome and opening remarks
7:15-8:15 p.m. Dinner and Lecture
8:15-8:45 p.m. Q & A session
8:45-9 p.m. Closing Remarks
Space is limited, so reserve your seat today. Online registration is required, go to https://hfhs.eventsair.com/CEPortal/hfhs/cme.
For attendees requiring accommodations, please contact The Townsend Hotel at (248) 642-7900 or visit townsendhotel.com to make arrangements.
ACCREDITATION STATEMENT:
Henry Ford Health System is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
DESIGNATION STATEMENT:
Henry Ford Health System designates this live course for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
FACULTY/PLANNING COMMITTEE DISCLOSURE STATEMENT:
In compliance with the ACCME Standards for Commercial Support, all individuals in a position to control/ influence the content of this activity are required to disclose relevant financial interests of their own or spouse or partners with any commercial interests and/or non-FDA approved use of drug or a device that is included in the presentation.
ENHANCING COMMUNICATION SERVICE FOR DEAF, HARD OF HEARING STATEMENT:
Henry Ford Health System provides, at no cost, qualified interpreters and other aids and services for the deaf and hard of hearing. To request assistance, call Kelly Soave at (313) 916-8522 or email ksoave1@hfhs.org. If possible, please notify us three days in advance of the event.